Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia

FetalEase Ltd. · NCT05913609

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · Women only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
80
US sites recruiting
4
Study start
November 15, 2023
Record last updated
November 25, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.

Being studied: Yaari Extractor

Conditions: Shoulder Dystocia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Subject 18 years of age or older at time of consent.
  • Subject planning on vaginal birth.
  • Singleton pregnancy in vertex presentation.
  • Full-term pregnancy having completed 37 weeks or more gestational weeks.
  • Able and willing to provide written informed consent prior to enrollment.
  • In the opinion of the Investigator, the subject has sufficient mental capacity to understand the informed consent form (ICF).
  • Subject with fetus experiencing shoulder dystocia as defined by ACOG Practice Bulletin 178 "Shoulder dystocia is most commonly diagnosed as failure to deliver the fetal shoulder(s) with gentle downward traction on the fetal head, requiring additional maneuvers to effect delivery."

Exclusion Criteria

  • Patients who have undergone attempted delivery using ancillary standard of care maneuvers, to include first-line maneuvers (McRoberts ± suprapubic pressure with downward traction on the fetal head), prior to use of the Yaari Extractor. (NOTE: Hyperflexion of the hips or legs is allowed prior to and during use of the Yaari Extractor.)
  • Cesarean section is planned for the patient.
  • Obstetric contraindications to vaginal birth.
  • Subject carrying fetus with known significant chromosomal or structural anomalies.
  • Clinically estimated fetal weight ≥5kg in non-diabetic subjects.
  • Clinically estimated fetal weight ≥4.5kg in subjects with diabetes.
  • Subject has any general health condition or systemic disease that may represent, in the opinion of the Investigator, a potential increased risk associated with device use or pregnancy.
  • Bleeding disorders, such as thrombocytopenia, von Willebrand's disease, bleeding disorder currently using anticoagulation medication, etc.
  • Any maternal disease or disorder that precludes the subject from pushing effectively.
  • If the maternal cervix is not fully dilated.
  • If the fetal head is not completely out of the birth canal.
  • In the presence of a non-reducible nuchal cord.

Recruiting US locations

  • University of Miami - Jackson Memorial

    Miami, FL 33136

    Site contact: Jemima Duroseau, BSN, RN, MPH · 305-689-8010 · jxp431@med.miami.edu

  • Rosemark WomenCare Specialist

    Idaho Falls, ID 83404

    Site contact: Nora Ramirez · 208-557-2924 · nramirez@rosemark.net

  • Unified Women's Clinical Research

    Winston-Salem, NC 27103

    Site contact: Nicole Cline · 336-955-8065 · nicole.cline@unifiedhc.com

  • Inova Fairfax Medical Campus

    Falls Church, VA 22042

    Site contact: Fatima Sahar, MBBS · 703-776-4600 · Sahar.Fatima@inova.org

Study contacts (from the official record)

  • Ahava Stein · +972522346927 · ahava@asteinrac.com